Antoni Wiedlocha funded by the EEA Poland-Norway grants
Antoni Wiedlocha
The proposal "Novel targeted therapy based on dual warhead conjugates against FGFR dependent cancers", with senior scientist Antoni Wiedlocha at Department of Molecular Cell Biology, Institute for Cancer Research, as Norwegian partner and professor Jacek Otlewski at the University of Wroclaw as Polish parther, has been awarded funding from the EEA Poland-Norway grants under the "Applied Research" programme.
Links:
From the National Centre for Research and Development in Poland:
Published in Level 2 journals, first or last author from Oslo University Hospital.
Poulsen M, Röhrl SM, Schulz A, Stødle AH(2025) Prospective Validation of a Weightbearing CT Stability Threshold for Subtle Lisfranc Injuries Foot Ankle Int, 10711007251374674(in press) DOI 10.1177/10711007251374674, PubMed 41170783
Andre KR, Telle HA, Negin K, Thorstein S, Juul SK, Kristin B(2025) Bowel function and quality of life in adolescents with Hirschsprung disease J Pediatr Surg, 162777(in press) DOI 10.1016/j.jpedsurg.2025.162777, PubMed 41167587
Høivik ML(2025) Optimising treatment in Crohn's disease: is the main issue early versus late or biologic naive versus biologic experienced? Lancet Gastroenterol Hepatol(in press) DOI 10.1016/S2468-1253(25)00258-4, PubMed 41167234